December 26, 2014 3:25 AM ET


Company Overview of RainDance Technologies, Inc.

Company Overview

RainDance Technologies, Inc. develops genomic tools for non-invasive liquid biopsy applications for the research, early detection, and treatment of cancer, inherited, and infectious diseases. It offers RainDrop, a digital polymerase chain reaction (PCR) solution; ThunderStorm, a targeted DNA sequencing system; ThunderBolts Cancer Panel, a DNA sequencing (NGS) solution that enables researchers to profile a range of tumor samples; peer-reviewed articles, including digital PCR, targeted DNA sequencing, and microdroplet applications articles, as well as technology reviews; and scientific posters, such as digital PCR and targeted DNA sequencing posters. The company serves major academic research ...

749 Middlesex Turnpike

Billerica, MA 01821

United States

Founded in 2004





Key Executives for RainDance Technologies, Inc.

Chief Executive Officer
Co-Founder and Chief Technology Officer
Chief Financial Officer
Age: 60
Compensation as of Fiscal Year 2014.

RainDance Technologies, Inc. Key Developments

RainDance Technologies, Inc. Announces Board Appointments

RainDance Technologies, Inc. announced the appointment of Martin M. Coyne II and Glenn P. Muir to its Board of Directors. Mr. Coyne currently serves as a director of Akamai, a role he has held since November 2001 and serves as Chairman of the Board of RockTech. Mr. Muir was Hologic's Chief Financial Officer from 1992 to May 2014 and Executive Vice President since 2000 with a broad range of financial and operating responsibilities including the oversight of the company's strategic initiatives.

RainDance Technologies Names John Luckey as Vice President of Product Development

RainDance Technologies has appointed John Luckey, Ph.D., as its new vice president of product development. Dr. Luckey brings more than 20 years of experience leading teams tasked with developing biotechnology systems and technology platforms. During his career, he has held senior product and platform development positions in companies including Roche NimbleGen, where he directed research and development activities for improving and expanding the company's core DNA microarray synthesis technology and related instrumentation. Dr. Luckey also managed product development and engineering activities at MJ Research, contributing to the design and development of the Opticon product family and Opticon Monitor software.

RainDance Technologies Names Frederick L. Eibel as Senior Vice President of Strategic Marketing

RainDance Technologies announced the appointment of Frederick L. Eibel as its new Senior Vice President of Strategic Marketing. Mr. Eibel brings more than two and a half decades of broad-based in vitro diagnostics and life science experience focused primarily on new and emerging growth opportunities. He most recently served as Head of Genetic Analysis Commercial Operations at Agena Bioscience.

Similar Private Companies By Industry

Company Name Region
Zymetis, Inc. United States
MitoSciences Inc. United States
Enterix Inc. United States
Dermelle, LLC United States
Integene International Holdings LLC United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact RainDance Technologies, Inc., please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at